Going Founder Mode on Cancer

2 days ago

Sid Sijbrandij, founder of GitLab, applied his 'radical transparency' and information-maximizing approach to his own cancer care after standard treatments failed.
He created a comprehensive care system including a 'Sid Health Notes' document, maximal diagnostics like single-cell sequencing, and a personalized 'therapeutic ladder' of treatments.
Sid's team repurposed existing drugs and developed new therapies, such as a radioligand therapy targeting fibroblast markers, leading to remission and immune response enhancement.
The journey highlights barriers in healthcare, like limited access to tissues and diagnostics, and the high cost and inefficiency of drug development under current regulatory paradigms.
Sid's story demonstrates the potential for personalized, data-driven oncology, using technologies like CAR-T and neoantigen vaccines, pointing to a future where such approaches could become scalable.
His experience underscores the need for systemic changes to align medical innovation, regulatory flexibility, and patient access, aiming to distribute advanced care more evenly.

Hasty Briefsbeta